Q2 2023 · 13F-HR
SECTOR GAMMA ASholdings as filed
Filed 2023-08-09 · accession 0000945621-23-000380
$446.9M
Reported value
29
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 375558103 | GILD | GILEAD SCIENCES INC | $46.3M | 10.4% | 601,367 | Common | SOLE |
| 14149Y108 | CAH | CARDINAL HEALTH INC | $36.4M | 8.14% | 384,642 | Common | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $32.5M | 7.26% | 507,576 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $30.5M | 6.83% | 346,508 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $27.3M | 6.10% | 95,757 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $24.7M | 5.54% | 397,532 | Common | SOLE |
| 075887109 | BDX | BECTON DICKINSON & CO | $24.5M | 5.49% | 92,923 | Common | SOLE |
| 98956P102 | ZBH | ZIMMER BIOMET HOLDINGS INC | $21.7M | 4.85% | 148,812 | Common | SOLE |
| 071813109 | BAX | BAXTER INTL INC | $21.6M | 4.83% | 473,634 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $18.4M | 4.12% | 195,291 | Common | SOLE |
| 50540R409 | LSI | LABORATORY CORP AMER HLDGS | $17.6M | 3.95% | 73,104 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $16.5M | 3.70% | 244,949 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $14.1M | 3.15% | 162,668 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $13.9M | 3.12% | 31,351 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $13.1M | 2.94% | 161,457 | Common | SOLE |
| 36266G107 | GEHC | GE HEALTHCARE TECHNOLOGIES I | $12.3M | 2.75% | 151,328 | Common | SOLE |
| 670704105 | NUVA | NUVASIVE INC | $11.1M | 2.48% | 266,370 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $8.3M | 1.86% | 112,242 | Common | SOLE |
| 148806102 | CTLTEUR | CATALENT INC | $7.8M | 1.75% | 180,088 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $6.6M | 1.47% | 160,401 | Common | SOLE |
| 023436108 | AMED | AMEDISYS INC | $6.5M | 1.45% | 71,007 | Common | SOLE |
| N72482123 | — | QIAGEN NV | $5.7M | 1.28% | 127,526 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $5.3M | 1.19% | 28,067 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $4.8M | 1.08% | 200,696 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $4.6M | 1.04% | 100,605 | Common | SOLE |
| 478160104 | JNJ | JOHNSON & JOHNSON | $4.4M | 0.98% | 26,471 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $4.2M | 0.94% | 50,309 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $3.7M | 0.83% | 150,406 | Common | SOLE |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $2.3M | 0.51% | 56,577 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.